Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
2 Reasons Why Eli Lilly's Mounjaro Might Beat Novo Nordisk's Ozempic, and 2 Reasons Why It Might Not
Motley Fool
Fri, 10/6/23 - 10:08 am
Novo Nordisk
Eli Lilly
Ozempic
Mounjaro
diabetes
weight loss
At Viatris' request, US agency will review another Novo Nordisk patent on semaglutide
Fierce Pharma
Thu, 10/5/23 - 10:21 am
Viatris
generics
Novo Nordisk
Ozempic
Wegovy
diabetes
patents
USPTO
Lilly names new diabetes and obesity chief as Mounjaro sales take off
BioPharma Dive
Wed, 10/4/23 - 11:23 pm
Eli Lilly
Mounjaro
diabetes
FDA Adds New Warning for Ileus to Ozempic Label
HCP Live
Thu, 09/28/23 - 11:55 am
Novo Nordisk
Ozempic
diabetes
weight losss
FDA
ileus
labeling
Why a hidden message in Ozempic’s logo represents a big shift in drug branding
Fast Company
Fri, 09/22/23 - 12:03 pm
Novo Nordisk
Ozempic
logo
branding
diabetes
weight loss
FDA panel votes against diabetes implant due to safety concerns
Reuters
Fri, 09/22/23 - 11:48 am
Intarcia
diabetes
FDA
ITCA 650
Medtech
Intarcia, a failed diabetes "unicorn," could be resurrected
Axios
Wed, 09/20/23 - 11:17 pm
Intarcia
FDA
diabetes
Eli Lilly sues clinics allegedly selling knockoff versions of Mounjaro diabetes drug
CNBC
Tue, 09/19/23 - 10:26 pm
Eli Lilly
legal
Mounjaro
diabetes
Novo Nordisk taps Aspen to help produce insulin for Africa
Fierce Pharma
Tue, 09/19/23 - 10:49 am
Novo Nordisk
diabetes
Africa
insulin
Aspen Pharmacare
drug manufacturing
How Payers Are Reacting to Insulin Price Changes
Drug Channels
Fri, 09/15/23 - 11:37 am
payers
insurance
insulin
diabetes
drug pricing
Inflation Reduction Act
Medicare
NICE changes its mind on Lilly's Mounjaro for diabetes
Pharmaphorum
Fri, 09/8/23 - 10:09 am
Eli Lilly
Mounjaro
diabetes
NHS
UK
Novo Nordisk Is Already Working on Ozempic 2.0
Motley Fool
Thu, 09/7/23 - 10:12 am
Novo Nordisk
diabetes
obesity
weight loss
Ozempic
Wegovy
Abbott and Bigfoot Take Relationship to the Next Level
Medical Devices and Diagnostics Industry
Tue, 09/5/23 - 08:49 pm
Abbott Labs
Bigfoot Biomedical
M&A
Medtech
diabetes
Eli Lilly infiltrates anti-obesity market as Phase III trial for retatrutide begins
Clinical Trials Arena
Thu, 08/31/23 - 06:02 pm
Eli Lilly
retatrutide
clinical trials
NASH
obesity
diabetes
type 2 diabetes
US senators push drugmakers for details on low-cost insulin programs
Yahoo/Reuters
Thu, 08/31/23 - 10:11 am
Senate
insulin
drug pricing
Novo Nordisk
Eli Lilly
Sanofi
diabetes
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
Motley Fool
Thu, 08/24/23 - 09:50 pm
Novo Nordisk
Ozempic
diabetes
weight loss
liver disease
addiction
cardiovascular disease
Medtronic pleased with Diabetes progress as new CGM’s FDA review ‘is progressing’
Mass Device
Wed, 08/23/23 - 09:59 am
Medtronic
Medtech
diabetes
FDA
continuous glucose monitoring
MiniMed 780G
Amazon Pharmacy rolls out insulin discount coupons
Pharmaphorum
Tue, 08/22/23 - 09:45 am
Amazon
Amazon pharmacy
insulin
discount coupons
diabetes
Lilly's $13.5M insulin pricing settlement gets pushback from 9 states
Fierce Pharma
Thu, 08/17/23 - 10:16 am
Eli Lilly
drug pricing
insulin
Humalog
legal
diabetes
Obesity, diabetes drugs push Novo Nordisk and Eli Lilly to front of pharma's growth pack in Q2
Fierce Pharma
Wed, 08/16/23 - 10:05 am
Novo Nordisk
Eli Lilly
obesity
diabetes
earnings
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »